FAD synthase (FMN:ATP adenylyl transferase, FMNAT or FADS, EC 184.108.40.206) is involved in the biochemical pathway for converting riboflavin into FAD. Human FADS exists in different isoforms. Two of these have been characterized and are localized in different subcellular compartments. hFADS2 containing 490 amino acids shows a two domain organization: the 30-phosphoadenosine-50-phosphosulfate (PAPS) reductase domain, that is the FAD-forming catalytic domain, and a resembling molybdopterin-binding (MPTb) domain. By a multialignment of hFADS2 with other MPTb containing proteins of various or-ganisms from bacteria to plants, the critical residues for hydrolytic function were identified. A homology model of the MPTb domain of hFADS2 was built, using as template the solved structure of a T. acidophilum enzyme. The capacity of hFADS2 to catalyse FAD hydrolysis was revealed. The recombinant hFADS2 was able to hydrolyse added FAD in a Co2þ and mersalyl dependent reaction. The recombinant PAPS reductase domain is not able to perform the same function. The mutant C440A catalyses the same hydrolytic function ofWT with no essential requirement for mersalyl, thus indicating the involvement of C440 in the control of hydrolysis switch. The enzyme C440A is also able to catalyse hydrolysis of FAD bound to the PAPS reductase domain, which is quantitatively converted into FMN.
|Titolo:||Human FAD synthase is a bi-functional enzyme with a FAD hydrolase activity in the molybdopterin binding domain|
|Parole Chiave:||Molybdopterin-binding domain; Human FAD synthase; FAD pyrophosphatase; FAD hydrolase; Cysteine; Redox switch|
|Settore Scientifico Disciplinare:||Settore BIO/10 - Biochimica|
|Data di pubblicazione:||2015|
|Digital Object Identifier (DOI):||10.1016/j.bbrc.2015.08.035|
|Appare nelle tipologie:||01 - Articolo su periodico|